Subfertility and Assisted Conception Study of Parent and Child Health Outcomes

生育力低下和亲子健康结果辅助受孕研究

基本信息

  • 批准号:
    9920765
  • 负责人:
  • 金额:
    $ 91.73万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-06-17 至 2022-03-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Subfertility, defined as delayed time-to-conception, affects an estimated 12% of women of reproductive age. The use of fertility-enhancing therapies, including assisted reproductive technologies (ART), has risen steadily in the United States due to several factors, including childbearing at older maternal ages and increasing insurance coverage. Prior studies of women's and children's health after ART have been limited by small sample sizes, non-US populations, or ART treatments performed more than a decade ago, and the lack of appropriate control groups. An important understudied area is that of non-ART fertility treatments and the perinatal, infant, and child health outcomes of these pregnancies. Our original pair of grants was the first population-based analysis of women's and children's health after ART to be conducted in the US. These studies, which had the unique strength of including a non-ART-treated subfertility comparison group, yielded a series of analyses suggesting that underlying subfertility, rather than the treatment modality, is the foundation for most maternal and child morbidity. In this renewal, we will expand this understanding through increased information on subfertility-related diagnoses, underlying non-subfertility medical conditions, non-ART treatment parameters, and outcome measures present in the All Payers Claims Database, as well as inclusion of new information on fathers. We will evaluate the health of mothers during pregnancy and for five years post-delivery, and their children through age four. The study population will include all Massachusetts women who delivered pregnancies between 2004 and 2011 (our original birth cohort) and their children, and will add study subjects who delivered between 2012 and 2017. The total study population will include more than one million families. Reference groups will include ART and non-ART pregnancies with only male factor infertility, and pregnancies without indicators or treatment of subfertility. The study aims and hypotheses are: Aim 1: To evaluate the effect of maternal subfertility diagnoses on long-term health; Hypothesis: Women with a history of subfertility diagnoses, independent of treatment, have higher risks of compromised health outcomes compared to women without indicators or treatment of subfertility; Aim 2: To evaluate the health of children born to women and men with subfertility diagnoses; Hypothesis: Children born to women and/or men with subfertility diagnoses, independent of treatment, have a higher risk of compromised health outcomes compared to children born to women without indicators of subfertility; and Aim 3: To develop a cost-of-subfertility measure for women and their children; Hypothesis: Women with a history of subfertility-related diagnoses and their children have higher healthcare costs compared to their counterparts without indicators or treatment of subfertility.
 描述(通过应用程序证明):定义为延迟到概念的差异,影响了估计使用增强疗法的12%,包括辅助生殖技术(ART),都在稳步上升,因为这是由于在任何因素上,均在联合的因素中稳步上升在旧样本中,将育儿的育儿限制在少量的情况下。对艺术后的妇女和儿童健康的分析,以独特的力量进行,包括包括未经艺术治疗的替代性比较一系列分析,表明属于大多数母亲和儿童发病率的基础,而不是治疗方式,而不是治疗方式。我们将扩大与Fatherity相关的信息的理解,这些信息是基本的非补充医疗分区,非ART治疗参数以及所有付款人索赔数据库中的结果指标。在送达后五年的母亲中,他们的四岁妇女妇女妇女妇女妇女妇女妇女妇女妇女妇女妇女的妇女将在2017年之间进行。米勒(Mille)的参考群体包括男性不育的非艺术妊娠,而没有指标或治疗的妊娠。 M健康:与治疗的史上,具有差异性的妇女具有更高的健康风险。独立于治疗,对儿童的健康状况较高,而没有指标的妇女及其妇女的妇女;与他们的对应物相比,没有指标或治疗副不动。

项目成果

期刊论文数量(23)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Contributions to prematurity of maternal health conditions, subfertility, and assisted reproductive technology.
  • DOI:
    10.1016/j.fertnstert.2020.03.036
  • 发表时间:
    2020-10
  • 期刊:
  • 影响因子:
    6.7
  • 作者:
    Stern JE;Liu CL;Hwang SS;Dukhovny D;Diop H;Cabral H
  • 通讯作者:
    Cabral H
The impact of single-step and sequential embryo culture systems on obstetric and perinatal outcomes in singleton pregnancies: the Massachusetts Outcomes Study of Assisted Reproductive Technology.
  • DOI:
    10.1016/j.fertnstert.2022.03.005
  • 发表时间:
    2022-06
  • 期刊:
  • 影响因子:
    6.7
  • 作者:
    Sacha, Caitlin R.;Gopal, Daksha;Liu, Chia-Ling;Cabral, Howard R.;Stern, Judy E.;Carusi, Daniela A.;Racowsky, Catherine;Bormann, Charles L.
  • 通讯作者:
    Bormann, Charles L.
Factors associated with increased odds of cesarean delivery in ART pregnancies.
  • DOI:
    10.1016/j.fertnstert.2018.04.032
  • 发表时间:
    2018-08
  • 期刊:
  • 影响因子:
    6.7
  • 作者:
    Stern JE;Liu CL;Cabral HJ;Richards EG;Coddington CC;Missmer SA;Diop H
  • 通讯作者:
    Diop H
Association of maternal fertility status and receipt of fertility treatment with healthcare utilization in infants up to age four.
Assisted reproductive technology treatment increases obstetric and neonatal risks over that of the underlying infertility diagnosis.
  • DOI:
    10.1016/j.fertnstert.2022.02.009
  • 发表时间:
    2022-06
  • 期刊:
  • 影响因子:
    6.7
  • 作者:
    Stern, Judy E.;Liu, Chia-Ling;Cui, Xiaohui;Cabral, Howard J.;Farland, Leslie, V;Coddington, Charles;Diop, Hafsatou
  • 通讯作者:
    Diop, Hafsatou
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hafsatou Diop其他文献

Hafsatou Diop的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hafsatou Diop', 18)}}的其他基金

Component A [Core]: Massachusetts Pregnancy Risk Assessment Monitoring System (PRAMS)
组件 A [核心]:马萨诸塞州妊娠风险评估监测系统 (PRAMS)
  • 批准号:
    10393199
  • 财政年份:
    2021
  • 资助金额:
    $ 91.73万
  • 项目类别:
RFA-DP-21-001 Component A [Core]: Massachusetts Pregnancy Risk Assessment Monitoring System (PRAMS)
RFA-DP-21-001 组件 A [核心]:马萨诸塞州妊娠风险评估监测系统 (PRAMS)
  • 批准号:
    10597173
  • 财政年份:
    2021
  • 资助金额:
    $ 91.73万
  • 项目类别:
Component A: [Core] Massachusetts Pregnancy Risk Assessment Monitoring System (PRAMS)
组件 A:[核心]马萨诸塞州妊娠风险评估监测系统 (PRAMS)
  • 批准号:
    9268411
  • 财政年份:
    2016
  • 资助金额:
    $ 91.73万
  • 项目类别:
Component A: [Core] Massachusetts Pregnancy Risk Assessment Monitoring System (PRAMS)
组件 A:[核心]马萨诸塞州妊娠风险评估监测系统 (PRAMS)
  • 批准号:
    9442268
  • 财政年份:
    2016
  • 资助金额:
    $ 91.73万
  • 项目类别:
MASSACHUSETTS PERINATAL QUALITY COLLABORATIVE
马萨诸塞州围产期质量合作组织
  • 批准号:
    8878578
  • 财政年份:
    2014
  • 资助金额:
    $ 91.73万
  • 项目类别:
B[Existing] - Massachusetts Pregnancy Risk Assessment Monitoring System (PRAMS)
B[现有] - 马萨诸塞州怀孕风险评估监测系统 (PRAMS)
  • 批准号:
    8466238
  • 财政年份:
    2011
  • 资助金额:
    $ 91.73万
  • 项目类别:
B[Existing] - Massachusetts Pregnancy Risk Assessment Monitoring System (PRAMS)
B[现有] - 马萨诸塞州怀孕风险评估监测系统 (PRAMS)
  • 批准号:
    8261847
  • 财政年份:
    2011
  • 资助金额:
    $ 91.73万
  • 项目类别:
B[Existing] - Massachusetts Pregnancy Risk Assessment Monitoring System (PRAMS)
B[现有] - 马萨诸塞州怀孕风险评估监测系统 (PRAMS)
  • 批准号:
    8841269
  • 财政年份:
    2011
  • 资助金额:
    $ 91.73万
  • 项目类别:
B[Existing] - Massachusetts Pregnancy Risk Assessment Monitoring System (PRAMS)
B[现有] - 马萨诸塞州怀孕风险评估监测系统 (PRAMS)
  • 批准号:
    8211961
  • 财政年份:
    2011
  • 资助金额:
    $ 91.73万
  • 项目类别:
B[Existing] - Massachusetts Pregnancy Risk Assessment Monitoring System (PRAMS)
B[现有] - 马萨诸塞州怀孕风险评估监测系统 (PRAMS)
  • 批准号:
    8656960
  • 财政年份:
    2011
  • 资助金额:
    $ 91.73万
  • 项目类别:

相似国自然基金

4-8岁儿童基于道德特征的选择性共情:发展及其机制
  • 批准号:
    32371111
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Elucidation of the molecular mechanisms of the RBM15-MKL1 fusion protein in acute megakaryoblastic leukemia
阐明RBM15-MKL1融合蛋白在急性巨核细胞白血病中的分子机制
  • 批准号:
    10597365
  • 财政年份:
    2023
  • 资助金额:
    $ 91.73万
  • 项目类别:
Mechanism of Mitochondria-induced Progressive Muscle Wasting
线粒体诱导进行性肌肉萎缩的机制
  • 批准号:
    10539303
  • 财政年份:
    2019
  • 资助金额:
    $ 91.73万
  • 项目类别:
Mechanisms underlying addiction to cocaine after traumatic injury to the developing rodent brain
发育中的啮齿动物大脑创伤后可卡因成瘾的机制
  • 批准号:
    9913381
  • 财政年份:
    2019
  • 资助金额:
    $ 91.73万
  • 项目类别:
Etiology of Nodding Syndrome: an Epileptic Disorder of East African Children
点头综合征的病因学:东非儿童的一种癫痫病
  • 批准号:
    9597149
  • 财政年份:
    2018
  • 资助金额:
    $ 91.73万
  • 项目类别:
Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma
疟疾对伯基特淋巴瘤病因中 EBV 免疫力的影响
  • 批准号:
    10655570
  • 财政年份:
    2014
  • 资助金额:
    $ 91.73万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了